Dr. Villoo Morawala-Patell Awarded For Achievement in Innovation And Creation Of Value
Award Conferred By The Adolfo Ibanez University
Tweet-- Dr. Villoo Morawala - Patell, Founder, Chairman and Managing Director of AVESTHAGEN LIMITED have been recognised by the Adolfo Ibanez University for her achievements in innovation and creation of value. This award was conferred upon her at the opening of VentureL@b by the president of Chile, Michelle Bachelet. VentureL@b is an initiative of Adolfo Ibáñez Business School which proposes an unprecedented way of getting scientific research and business together.
Accepting the award, Dr Patell said, “I have always been driven by innovation and creation of value. It is indeed a great honour to be recognised for the same values. AVESTHAGEN LIMITED stands on the same principles and our aim has always been to explore new frontiers in science through innovation.”
Dr Villoo Morawala-Patell is a scientist and businesswoman. She established Avesthagen in April 1998 to develop research in Life Sciences and promote sustainable innovation platform in India. The company today is India’s leading knowledge based Life Sciences Company. It is focused on partnering to achieve a broad spectrum leading to convergence of food, pharma and population genetics aimed at delivering complete healthcare solutions. A few of the company’s partners include Danone, Vilmorin & Cie and CIPLA.
Dr Patell also has the following awards to her credit:
- Zee-Archana Astitva Awards 2008 for Excellence in Science and Technology
- The Officer of the National Order of Merit Award from the French President in 2008.
- The Parsi Entrepreneur Par Excellence Award from the Bombay Parsi Panchayat in 2008
- BioSpectrum Entrepreneur of the Year Award 2006
- Outstanding Woman Entrepreneur for the year 2005-2006 from FICCI
- The Ojaswani Udyamita Alankaran Award 2004
Notes to Editor
About Avesthagen Limited
AVESTHAGEN LIMITED (www.avesthagen.com) is India’s leading integrated systems biology platform company that focuses on achieving convergence of food, pharma and population genetics leading to predictive preventive and personalized healthcare. It employs 600 people worldwide and is headquartered in Bangalore. Avesthagen Limited has established world class, state-of-the-art laboratory facilities in Bangalore. It began business operations in 2001.Since its inception Avesthagen has grown into one of India's leading healthcare technology group in India, and its activities include, in addition to its agri-biotechnologies product pipeline, development of clinically validated botanical bioActives, derived from Indian medicinal plants, as well as the development of a pipeline of bio-similar drugs. Avesthagen Limited has four strategic business units: bioPharmaceuticals, bioNutrition, bioAgriculture and Science & Innovation. Its partners include multiple top 10 global companies in each of its fields of research. Avesthagen Limited collaborates at every stage in the value chain with appropriate partners, both public and private, for access to and exchange of technology and overall commercial expertise to leverage the ‘India advantage’.
Disclaimer
Avesthagen Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a public issue of its equity shares and to file a Draft Red Herring Prospectus with SEBI. This announcement does not constitute an offer of equity shares for sale in any jurisdiction, including the United States of America, and any equity shares of the Company may not be offered or sold in the United States absent registration under the United States Securities Act of 1933, as amended, or pursuant to an exemption from registration